Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Samuel Fatoba
Discontinuation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Population-Based Cohort Study Using Primary Care Data From the Health Improvement Network in the UK
BMJ Open
Medicine
Related publications
Correction: Discontinuation of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation: A Population-Based Cohort Study Using Primary Care Data From the Health Improvement Network in the UK
BMJ Open
Medicine
Impact of Non-Vitamin K Antagonist Oral Anticoagulants on Intracranial Bleeding in Asian Patients With Non-Valvular Atrial Fibrillation
Circulation Journal
Medicine
Cardiovascular Medicine
Cardiology
Comparative Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation: Propensity Weighted Nationwide Cohort Study
British Medical Journal
Medicine
Comparative Effectiveness of Novel Oral Anticoagulants in UK Patients With Non-Valvular Atrial Fibrillation and Chronic Kidney Disease: A Matched Cohort Study
BMJ Open
Medicine
Overview of the Non-Vitamin K Oral Anticoagulants for Atrial Fibrillation
Therapeutic Advances in Cardiovascular Disease
Cardiovascular Medicine
Pharmacology
Cardiology
Prm20 - Clinical Effectiveness and Safety of Standard-Dose and Low-Dose Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation: A Nationwide Population-Based Cohort Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Comparison of Non-Vitamin K Antagonist Oral Anticoagulants Versus Well-Managed Warfarin With a Lower INR Target of 1.5 to 2.5 in Asians Patients With Non-Valvular Atrial Fibrillation
PLoS ONE
Multidisciplinary
Long-Term Vitamin K Antagonists Treatment Patterns of Non-Valvular Atrial Fibrillation (NVAF): A Population-Based Cohort Study
BMC Cardiovascular Disorders
Cardiovascular Medicine
Cardiology
Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants
Journal of Medical Economics
Health Policy
